FUKUSHIMA JOURNAL OF MEDICAL SCIENCE
Online ISSN : 2185-4610
Print ISSN : 0016-2590
ISSN-L : 0016-2590

This article has now been updated. Please use the final version.

Fundamental study of digital subtraction angiography using dose characteristic analysis of different protocols in lower limb arterial disease
Kazuya KakutaKoichi ChidaMasamichi NaruseShumpei NemotoMasamitsu IkedaArifumi Hasegawa
Author information
JOURNAL OPEN ACCESS FULL-TEXT HTML Advance online publication

Article ID: 25-00015

Details
Abstract

Abstract

We clarified the differences between the two pre-set protocols for iodine-digital subtraction angiography (ICM-DSA) and carbon dioxide (CO2)-DSA in terms of radiation exposure to patients and physicians when patients diagnosed with lower extremity artery disease (LEAD) undergo ICM-DSA or CO2-DSA, and identified factors that affect radiation exposure when patients undergo ICM-DSA or CO2-DSA. CO2-and ICM-DSA yielded 149 and 272 vessels in 21 and 49 patients, respectively. Multiple regression analyses revealed strong positive linear correlations between total air kerma (kinetic energy released per unit mass) at the patient entrance reference point (Ka,r), the total kerma area product (KAP), and the total number of acquisitions for ICM-DSA and CO2-DSA, respectively. Compared to Ka,r, there were significant differences in the tube potentials, KAP, and spectral shaping filters in both DSA procedures. The linear correlations between Ka,r and the number of ICM-DSA and CO2-DSA images varied among dose types, with strong linear correlations observed when Ka,r was classified into the above three groups. The X-ray conditions for each DSA image differed, with CO2-DSA using a significantly higher tube potential and different spectral shaping filters compared to ICM-DSA. When performing DSA for LEAD, an optimized protocol for each type of ontrast agent should be used.

Content from these authors
© 2025 The Fukushima Society of Medical Science

This article is licensed under a Creative Commons [Attribution-NonCommercial-ShareAlike 4.0 International] license.
https://creativecommons.org/licenses/by-nc-sa/4.0/
feedback
Top